Filing Flows › Nektar Therapeutics (NKTR) › How it makes money
How Nektar Therapeutics (NKTR) makes money
Nektar Therapeutics (NKTR) made $10.1M of revenue in the second quarter 2026 (Q2 2026), -9% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $10.1M | 100.0% |
| Income tax | $2K | 0.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $10.1M | -9% |
| Q1 2026 | $10.9M | +4% |
| Q4 2025 | $21.8M | -25% |
| Q3 2025 | $11.8M | -51% |
| Q2 2025 | $11.2M | -52% |
| Q1 2025 | $10.5M | -52% |
| Q4 2024 | $29.2M | +22% |
From Nektar Therapeutics' 10-Q filed Aug 14, 2026 (on EDGAR).
Questions
How does Nektar Therapeutics make money?
Nektar Therapeutics (NKTR) made $10.1M of revenue in the second quarter 2026 (Q2 2026), -9% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.